In Vivo Toxicology Market worth 6.14 Billion USD by 2022

By -

The in vivo toxicology market is expected to reach USD 6.14 Billion by 2022 from an estimated USD 4.40 Billion in 2017, at a CAGR of 6.9%.

(EMAILWIRE.COM, February 19, 2018 ) Browse 124 tables and 38 figures spread through 196 pages and in-depth TOC on "In Vivo Toxicology Market"
https://www.marketsandmarkets.com/Market-Reports/in-vivo-toxicology-testing-market-105308811.html
Early buyers will receive 10% customization on this report.

The key factors driving the growth of this market include increasing pharmaceutical R&D activities, mandatory government regulations for animal testing, innovations in animal models, and the development of exclusive in vivo toxicology tests.

The consumables segment is expected to hold the largest share of the market

Based on product, the in vivo toxicology market is segmented into consumables and instruments. The consumables segment is further divided into reagents & kits and animal models.

In 2017, the consumables segment is expected to account for the largest share of the in vivo toxicology market owing to the increasing R&D funding for the development of new transgenic animal models, advancements in the development of genetically modified animals, increasing usage of reagents and kits for biological sample analysis.

By testing type, sub-acute toxicity testing to register the highest CAGR during the forecast period

Download the PDF Brochure@
https://www.marketsandmarkets.com/pdfdownload.asp?id=105308811

The in vivo toxicology market is segmented by testing type into chronic, sub-chronic, sub-acute, and acute toxicology testing. In 2017, the sub-acute toxicity testing segment is expected to register the highest CAGR of during the forecast period. Growth in this market is attributed to the increasing focus on neurological and anti-viral drug research, which requires more than two weeks of toxicity studies.

The US is expected to dominate the in vivo toxicology market in 2017

In 2017, the US is estimated to account for the largest share of the in vivo toxicology market, followed by Germany and the UK. However, China is expected to grow at the highest CAGR during the forecast period.

Factors such as rising R&D funding and collaborations; initiatives by the Chinese government to promote life science research; and the strong trend of commercialization of biotechnology research are contributing to the growth of the in vivo toxicology market in China.

The major players in the global in vivo toxicology market include Thermo Fisher (US), Danaher (US), Charles River (US), Covance (LabCorp), and The Jackson Laboratory (US).

Get the Sample Pages@
https://www.marketsandmarkets.com/requestsample.asp?id=105308811

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

Read other news from MarketsandMarkets™

Timing Devices Market Size, Share, Revenue Trends & Forecast to 2030

MarketsandMarkets™ - Sep 18, 2023
Timing Devices Market by Type (Oscillators, Atomic Clocks, Clock Generators, Clock Buffers, Jitter Attenuators), Material (Crystal, Silicon, Ceramic), Vertical (Consumer Electronics, Automotive) and Region - Global Forecast to 2030 ...Read more

Artificial Intelligence Market Segmented by Product, Top Manufacturers, Geography Trends & Growth Opportunity to 2030

MarketsandMarkets™ - Sep 18, 2023
Artificial Intelligence technology such as machine learning, natural language processing, computer vision, and others are revolutionizing various sectors, including healthcare, finance, manufacturing, and retail. ...Read more

Digital PCR (dPCR) and Real-time PCR (qPCR) Market worth $12.4 billion by 2028, at a CAGR of 7.8%.

MarketsandMarkets™ - Sep 18, 2023
"Digital PCR (dPCR) and Real-time PCR (qPCR) Market by Product (Instruments, Reagents & Consumables, Software & Services), Application (Clinical, Research, Forensic), End User (Hospital, Diagnostic Labs, Pharma, Biotech, CROs) - Global Forecast to 2028". ...Read more